Document is current
Any future updates will be listed below
-
Authors
Biasiotto, Roberta https://orcid.org/0000-0002-8845-9670
Kösters, Maria
Tschigg, Katharina https://orcid.org/0000-0001-5146-3492
Pramstaller, Peter P. https://orcid.org/0000-0002-9831-8302
Brüggemann, Norbert
Borsche, Max https://orcid.org/0000-0002-9651-5986
Klein, Christine https://orcid.org/0000-0003-2102-3431
Hicks, Andrew A. https://orcid.org/0000-0001-6320-0411
Mascalzoni, Deborah https://orcid.org/0000-0003-4156-1464
- License Information
-
More Information
Article History
Received: 2 August 2021
Revised: 27 October 2022
Accepted: 15 December 2022
First Online: 4 January 2023
Competing interests
: CK serves as a medical advisor to Centogene for genetic testing reports in the field of movement disorders and dementia, excluding Parkinson’s disease. NB served as a consultant for BridgeBio and Centogene and is member of the scientific advisory board of BridgeBio. The other authors declare that they have no competing interests.
: The study was approved by the ethics committee of the Azienda Sanitaria dell’Alto Adige. Participants provided written informed consent to participate in the study.
